In line with the ALK4-SMAD2/3-SMAD4 signaling pathway corroborated in this study, the role of activin A in leiomyoma cells is thought to be mediated by activation of the SMAD2/3 signaling pathway [70, 71]. This evidence concerns the gene ACVR1B and leiomyoma.